| Application no. and date | 15156029.9 (espacenet) (Federated) (European Patent Register), 20050804 | | Patent/reg. no. and date | DK/EP 2902039, 20180411 | | Publication date | 20150805 | | Priority no. and date | GB 0417487, 20040805 | | EP pub. no. and date |
EP 2902039 20150805 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/156987 | | Inventor | GRAM, Hermann, Am Bischofsacker 20
79576 Weil am Rhein, DE,
Hofstetter, Hans, Chrischonaweg 92
4125 Riehen, CH,
Jeschke, Margit, Grenzacher Strasse 10
4058 Basel, CH,
Rondeau, Jean-Michel, Novartis Pharma AG
Postfach
4002 Basel, CH,
Van den Berg, Wim, Ridderlaan 12
6584 CB Molenhoek, NL,
Di Padova, Franco E, Kluenenfeldstrasse 45
4127 Birsfelden, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 29/00 (2006.01) , C07K 16/24 (2006.01) | | Title | IL-17 antagonistiske antistoffer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2018 00035 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
